Why the study?
Is the Six-Minute Walk Test a reliable and valid clinical outcome measure in ambulatory spinal muscular atrophy?
Is the Six-Minute Walk Test a reliable and valid clinical outcome measure in ambulatory spinal muscular atrophy?
The 6MWT is a reliable and valid outcome measure that discriminates disease severity in ambulatory spinal muscular atrophy, supporting its use in clinical trials.
Answers are grounded in this paper and cite their sources.
Supports 6MWT as reliable outcome in ambulatory SMA; leaves open prospective validation before routine adoption.
INTRODUCTION: The Six-Minute Walk Test (6MWT) was adopted as a clinical outcome measure for ambulatory spinal muscular atrophy (SMA). However, a systematic review of measurement properties reported significant variation among chronic pediatric conditions. Our purpose was to assess the reliability/validity of the 6MWT in SMA. METHODS: Thirty participants performed assessments, including the 6MWT, strength, and function. Reproducibility was evaluated by intraclass correlation coefficients. Criterion/convergent validity were determined using Pearson correlation coefficients. RESULTS: Test-retest reliability was excellent. The 6MWT was associated positively with peak oxygen uptake, Hammersmith Functional Motor Scale Expanded (HFMSE), lower extremity manual muscle testing, knee flexion hand-held dynamometry, and inversely with 10-m walk/run. The 6MWT discriminates between disease severity, unlike the HFMSE. CONCLUSIONS: This study documents measurement properties of reproducibility, positive criterion validity, and convergent validity with established clinical assessments and reaffirms the value of the 6MWT as a pivotal outcome measure in SMA clinical trials. Muscle Nerve 54: 836-842, 2016.
No takes yet. Share an insight, caveat, or question.
Young et al. (2016) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: